Identification of platelet function defects by multi-parameter assessment of thrombus formation

Nature Communications

Volumn 5, Issue , 2014, Pages

  De Witt, Susanne M ^a   Swieringa, Frauke ^a   Cavill, Rachel ^b   Lamers, Moniek M E ^a   Van Kruchten, Roger ^a   Mastenbroek, Tom ^a   Baaten, Constance ^a   Coort, Susan ^b   Pugh, Nicholas ^c   Schulz, Ansgar ^d   Scharrer, Inge ^e   Jurk, Kerstin ^e   Zieger, Barbara ^f   Clemetson, Kenneth J ^g   Farndale, Richard W ^h   Heemskerk, Johan W M ^a   Cosemans, Judith M E M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c ANGLIA RUSKIN UNIVERSITY   (United Kingdom)

^d UNIVERSITY HOSPITAL ULM   (Germany)

^e UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^f UNIVERSITY OF FREIBURG   (Germany)

^g UNIVERSITY OF BERN   (Switzerland)

^h UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; GLYCOPROTEIN VI; LECTIN RECEPTOR; VERY LATE ACTIVATION ANTIGEN 2; VERY LATE ACTIVATION ANTIGEN 5; VERY LATE ACTIVATION ANTIGEN 6; VITRONECTIN RECEPTOR; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD CLOTTING; CELL SURFACE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GLANZMANN DISEASE; GRAY PLATELET SYNDROME; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN TISSUE; MALE; MAY HEGGLIN ANOMALY; NORMAL HUMAN; OCULAR ALBINISM; SEVERE COMBINED IMMUNODEFICIENCY; SHEAR RATE; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE ANOMALY; THROMBOCYTOPENIA; BIOASSAY; BIOLOGY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; THROMBOSIS; YOUNG ADULT;

ADULT; BIOLOGICAL ASSAY; COMPUTATIONAL BIOLOGY; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; THROMBOSIS; YOUNG ADULT;

EID: 84904498391     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms5257     Document Type: Article

References (53)

1. Jackson, S. P. Arterial thrombosis: Insidious, unpredictable and deadly. Nat. Med. 17, 1423-1436 (2011
2. Ruggeri, Z. M. & Mendolicchio, G. L. Adhesion mechanisms in platelet function. Circ. Res. 100, 1673-1685 (2007 (Pubitemid 46987859)
3. Jackson, S. P. The growing complexity of platelet aggregation. Blood 109, 5087-5095 (2007 (Pubitemid 46890522)
4. Versteeg, H. H., Heemskerk, J. W., Levi, M. & Reitsma, P. S. New fundamentals in hemostasis. Physiol. Rev. 93, 327-358 (2013
5. Sakariassen, K. S., Muggli, R. & Baumgartner, H. R. Measurements of platelet interaction with components of the vessel wall in flowing blood. Meth. Enzymol. 169, 37-70 (1989 (Pubitemid 19101520)
6. Savage, B. & Ruggeri, Z. M. Selective recognition of adhesive sites in surfacebound fibrinogen by glycoprotein IIb-IIIa on nonactivated platelets. J. Biol. Chem. 266, 11227-11233 (1991 (Pubitemid 21906936)
7. Konopatskaya, O. et al. Protein kinase C mediates platelet secretion and thrombus formation through protein kinase D2. Blood 118, 416-424 (2011
8. Stegner, D. & Nieswandt, B. Platelet receptor signaling in thrombus formation. J. Mol. Med. 89, 109-121 (2011
9. Roest, M., Reininger, A., Zwaginga, J. J., King, M. R. & Heemskerk, J. W. Flow chamber-based assays to measure thrombus forma tion in vitro: Requirements for standardization. J. Thromb. Haemost. 9, 2322-2324 (2011
10. Okorie, U. M. & Diamond, S. L. Matrix protein microarrays for spatially and compositionally controlled microspot thrombosis under laminar flow. Biophys. J. 91, 3474-3481 (2006 (Pubitemid 44788281)
11. Grabowski, E. F., Yam, K. & Gerace, M. Evaluation of hemostasis in flowing blood. Am. J. Hematol. 87, S51-S55 (2012
12. Tsai, M. et al. In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology. J. Clin. Invest. 122, 408-418 (2011
13. Westein E. de Witt S. Lamers M. Cosemans J. M. Heemskerk J. W.Monitoring in vitro thrombus formation with novel microfluidic devices. Platelets.23. 501-509 (2012).
14. Westein, E., de Witt, S., Lamers, M., Cosemans, J. M. & Heemskerk, J. W. Monitoring in vitro thrombus formation with novel microfluidic devices. Platelets 23, 501-509 (2012). 14. Neeves, K. B. et al. Sources of variability in platelet accumulation on type 1 fibrillar collagen in microfluidic flow assays. PLoS ONE 7, e54680 (2013
15. Flamm, M. H. et al. Multiscale prediction of patient-specific platelet function under flow. Blood 120, 190-198 (2012
16. Hosokawa, K. et al. Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions. Thromb. Haemost. 109, 102-111 (2013
17. Mendolicchio, G. L. et al. Variable effect of P2Y12 inhibition on platelet thrombus volume in flowing blood. J. Thromb. Haemost. 9, 373-382 (2011
18. Harrison, P. et al. Guidelines for the laboratory investigations of heritable disorders of platelet function. Br. J. Haematol. 155, 30-44 (2011
19. Farndale, R. W., Sixma, J. J., Barnes, M. J. & de Groot, P. G. The role of collagen in thrombosis and haemostasis. J. Thromb. Haemost. 2, 561-573 (2004
20. Gibbins, J. M. Platelet adhesion signalling and the regulation of thrombus formation. J. Cell. Sci. 117, 3415-3425 (2004 (Pubitemid 39206382)
21. Savage, B., Saldivar, E. & Ruggeri, Z. M. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 84, 289-297 (1996 (Pubitemid 26040846)
22. Siljander, P. R. et al. Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood. Blood 103, 1333-1341 (2004 (Pubitemid 38168645)
23. Auger, J. M., Kuijpers, M. J., Senis, Y. A., Watson, S. P. & Heemskerk, J. W. Adhesio n of human and mouse platelets to collagen under shear: A unifying model. FASEB J. 19, 825-827 (2005 (Pubitemid 40617397)
24. Munnix, I. C. et al. Collagen-mimetic peptides mediate flow-dependent thrombus formation by high-or low-affinity binding of integrin a2b1 and glycoprotein VI. J. Thromb. Haemost. 6, 2132-2142 (2008
25. Van deWalle, G. R. et al. Activation of aIIbb3 is a sufficient but also an imperative prerequisite for activation of a2b1 on platelets. Blood 109, 595-602 (2007
26. Heemskerk, J. W., Mattheij, N. & Cosemans, J. M. Platelet-based coagulation: Different populations, different functions. J. Thromb. Haemost. 11, 2-11 (2013
27. Endenburg, S. C., Lindeboom-Blokzijl, L., Zwaginga, J. J., Sixma, J. J. & de Groot, P. G. Plasma fibrinogen inhibits platelet adhesion in flowing blood to imm obilized fibrinogen. Arterioscler. Thromb. Vasc. Biol. 16, 633-638 (1996 (Pubitemid 26153107)
28. Chada, D., Mather, T. & Nollert, M. U. The synergy site of fibronectin is required for strong interaction with the platelet integrin aIIbb3. Ann. Biomed. Engin. 34, 1542-1552 (2006
29. Asch, E. & Podack, E. Vitronectin binds to activated human platelets and plays a role in platelet aggregation. J. Clin. Invest. 85, 1372-1378 (1990 (Pubitemid 20176428)
30. Wu, Y. P. et al. Fibrin-incorporated vitronectin is involved in platelet adhesion and thrombus formation through homotypic interactions with plateletassociated vitro nectin. Blood 104, 1034-1041 (2004
31. Inoue, O. et al. Laminin stimulates spreading of platelets through integrin a6b1-dependent activation of GPVI. Blood 107, 1405-1412 (2006 (Pubitemid 43242375)
32. Inoue, O., Suzuki-Inoue, K. & Ozaki, Y. Redundant mechanism of platelet adhesion to laminin and collagen under flow: Involvement of von Willebrand factor and glycoprotein Ib-IX-V. J. Biol. Chem. 283, 16279-16282 (2008
33. Jurk, K. et al. Thrombospondin-1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): An alternative/backup mechanism to von Willebrand factor. FASEB J. 17, 1490-1492 (2003
34. May, F. et al. CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis. Blood 114, 3464-3472 (2009
35. Suzuki-Inoue, K. et al. Essential in vivo roles of the C-type lectin receptor CLEC-2: E mbryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets. J. Biol. Chem. 285, 24494-24507 (2010).
36. Severin S. et al Syk-dependent phosphorylation of CLEC-2: A novel mechanism of hem-immunoreceptor tyrosine-based activation motif signaling. J. Biol. Chem. 286 4107-4116 (2011).
37. Pugh, N. et al. Synerg ism between platelet collagen receptors defined using receptor-specific collagen-mimetic peptide substrata in flowing blood. Blood 115, 5069-5079 (2010
38. Van Kruchten, R., Cosemans, J. M. & Heemskerk, J. W. Measurement of whole blood thrombus formation using parallel-plate flow chambers: A practical guide. Platelets 23, 229-242 (2012
39. Heemskerk, J. W. et al. Collagen surfaces to measure thrombus formation under flow: Possibilities for standardization. J. Thromb. Haemost. 9, 856-858 (2011
40. Bergmeier, W. et al. R93W mutation in Orai1 causes impaired calcium influx in platelets. Blood 113, 675-678 (2009
41. Nurden, A. & Nurden, P. Advances in our understanding of the molecular basis of disorders of platelet function. J. Thromb. Haemost. 9(Suppl. 1): 76-91 (2011
42. Schaff, M. et al. Integrin a6b1 is the main receptor for vascular laminins and plays a role in platelet adhesion, activation and arterial thrombosis. Circulation 128, 541-552 (2013
43. Ozaki, Y., Suzuki-Inoue, K. & Inoue, O. Novel interactions in platelet biology: CLEC-2/podoplanin and laminin/GPVI. J. Thromb. Haemost. 7(Suppl 1): 191-194 (2009
44. Lisman, T. et al. A single high-affinity binding site for von Willebrand factor in collagen III, identified using synthetic triple-helical peptides. Blood 108, 3753-3756 (2006 (Pubitemid 44864555)
45. W estein, E. et al. Atherosclerotic geometries spatially confine and exacerbate pathological thrombus formation poststenosis in a von Willebrand factordependent manner. Proc. Natl Acad. Sci. USA 110, 1357-1362 (2013
46. Hooley, E. et al. The crystal structure of the platelet activator aggretin reveals a novel (ab)2 dimeric structure. Biochemistry 47, 7831-7837 (2008
47. Knight, C. G. et al. Identification in collagen type I of an integrin a2b1-binding site containing an essential GER sequence. J. Biol. Chem. 273, 33287-33294 (1998 (Pubitemid 29005704)
48. Smethurst, P. A. et al. Identification of the primary coll agen-binding surface on human glycoprotein VI by site-directed mutagenesis and by a blocking phage antibody. Blood 103, 903-911 (2004 (Pubitemid 38129549)
49. Cauwenberghs, N. et al. Epitope mapping of inhibitory antibodie s against platelet glycoprotein Iba reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Iba. Blood 98, 652-660 (2001
50. Rosado, J. A. et al. Fibrinogen binding to the integrin aIIbb3 modulates store-mediated calcium entry in human platelets. Blood 97, 2648-2656 (2001
51. Feske, S. et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441, 179-185 (2006
52. Munnix, I. C. et al. Segregation of platelet aggregatory and procoagulant microdomains in thrombus formation: ReGuLaTiOn bY TrAnSiEnT InTeGrIn aCtIvAtIoN. ARtErIoScLer. Thromb. Vasc. Biol. 27, 2484-2490 (2007 (Pubitemid 350203968)
53. Cosemans, J. M. et al. Key role of glycoprotein Ib/V/IX and von Willebrand factor in platelet activation-dependent fibrin formation at low shear flow. Blood 117, 651-660 (2011).